EXPO vs ECG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
EXPO
ECG
Investment Advisor Scores
ECG
AI Analyst Insights
Detailed Metrics Comparison
| Metric | EXPO | ECG | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 31.5457 | 19.2308 | ECG |
| PEG Ratio | 2.0325 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 12.0% | 33.7% | ECG |
| Earnings Growth | 15.7% | 59.2% | ECG |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 31.7/100 | 39.6/100 | ECG |
| Profit Margin | 19.7% | 6.0% | EXPO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | AVOID NEW MONEY | EXPO |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EXPO
MarkupPrice above SMA50, rising 50-day trend (2.9% over 20 days), RSI 77
ECG
MarkdownPrice below a falling SMA50 (slope -4.9%), weak momentum, RSI 26
Fundamentals Snapshot
| Metric | EXPO | ECG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 28.4 | 15.4 |
| Trailing P/E | 32.5 | 21.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.3% |
| Gross Margin | 0.4% | 0.1% |
| Operating Margin | 0.2% | 0.1% |
| EPS | 2.25 | 4.97 |
| Dividend Yield | 0.02% | — |